Huang Hongyun, Oizumi Shunsuke, Kojima Nobuhiko, Niino Toshiki, Sakai Yasuyuki
Center for Disease Biology and Integrative Medicine (CDBIM), Gradate School of Medicine, University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8655, Japan.
Biomaterials. 2007 Sep;28(26):3815-23. doi: 10.1016/j.biomaterials.2007.05.004. Epub 2007 May 18.
To engineer implantable liver tissues, we designed a novel scaffold with a three-dimensional (3D) branching and joining flow-channel network comprising multiple tetrahedral units (4-mm edge length). For the fabrication of this network, biodegradable polycaprolactone (PCL) and 80% (w/w) NaCl salt particles serving as porogen were thoroughly mixed and applied in a selective laser sintering (SLS) process, a technique adapted to rapid prototyping. We thus obtained a scaffold that had high (89%) porosity with a pore size of 100-200 microm and 3D flow channels. To evaluate its biocompatibility, human hepatoma Hep G2 cells were seeded into the scaffold using avidin-biotin (AB) binding and cultured in a perfusion system for 9 days. The results demonstrated that such 3D flow channels are essential to the cells' growth and function. In addition, the AB binding-based seeding remarkably improved the overall performance of the cell-loaded scaffolds. The fabrication of a much finer scaffold, having a 500 cm(3) scale, based on the same design and the use of human hepatocyte progenitors, may, in the near future, lead to the development of an implantable liver tissue equivalent for use in humans.
为构建可植入的肝组织,我们设计了一种新型支架,其具有包含多个四面体单元(边长4毫米)的三维(3D)分支和连接流道网络。为制造该网络,将可生物降解的聚己内酯(PCL)和用作致孔剂的80%(重量/重量)氯化钠盐颗粒充分混合,并应用于选择性激光烧结(SLS)工艺中,这是一种适用于快速成型的技术。由此我们获得了一种孔隙率高(89%)、孔径为100 - 200微米且具有3D流道的支架。为评估其生物相容性,使用抗生物素蛋白 - 生物素(AB)结合法将人肝癌Hep G2细胞接种到支架中,并在灌注系统中培养9天。结果表明,此类3D流道对细胞的生长和功能至关重要。此外,基于AB结合的接种方法显著改善了负载细胞的支架的整体性能。基于相同设计并使用人肝祖细胞制造一个规模为500立方厘米的更精细支架,在不久的将来可能会促使可用于人类的可植入肝组织等效物的开发。